triiodothyronine and Chronic Illness studies

Triiodothyronine: A T3 thyroid hormone normally synthesized and secreted by the thyroid gland in much smaller quantities than thyroxine (T4). Most T3 is derived from peripheral monodeiodination of T4 at the 5' position of the outer ring of the iodothyronine nucleus. The hormone finally delivered and used by the tissues is mainly T3.
3,3',5-triiodo-L-thyronine : An iodothyronine compound having iodo substituents at the 3-, 3'- and 5-positions. Although some is produced in the thyroid, most of the 3,3',5-triiodo-L-thyronine in the body is generated by mono-deiodination of L-thyroxine in the peripheral tissues. Its metabolic activity is about 3 to 5 times that of L-thyroxine. The sodium salt is used in the treatment of hypothyroidism.

Research Excerpts

Excerpt	Relevance	Reference
"In this study, 93 chronic inpatients with schizophrenia were comprehensively investigated in order to examine the association of psychiatric and extrapyramidal symptoms with prolactin, thyroid hormones (free triiodothyronine (T₃), free thyroxine (T₄), thyroid stimulating hormone), cortisol and BDNF."	7.78	Triiodothyronine may be possibly associated with better cognitive function and less extrapyramidal symptoms in chronic schizophrenia. ( Hoaki, N; Hoaki, T; Ichioka, S; Matsushita, T; Terao, T, 2012)
"The objective of this paper was to investigate the diagnostic and prognostic value of plasma B type natriuretic peptide (BNP) and serum triiodothyronine (T3) in chronic congestive heart failure (CHF)."	7.78	The role of brain natriuretic peptide and serum triiodothyronine in the diagnosis and prognosis of chronic heart failure. ( Da, CH; Du, JB; Guo, G; Guo, Y; Ju, TF; Xu, YP; Zhao, Y, 2012)
"Although low levels of free triiodothyronine and high levels of brain natriuretic peptide have been shown as independent predictors of death in chronic heart failure patients, few studies have compared their prognostic values."	7.76	Triiodothyronine and brain natriuretic peptide: similar long-term prognostic values for chronic heart failure. ( Acar, E; Ertas, G; Kilic, T; Kozdag, G; Sahin, T; Ural, D, 2010)
"We sought to explore the use of triiodothyronine (T(3)) concentrations as an adjunct to clinical and functional parameters when estimating prognosis in patients with chronic heart failure."	7.73	Triiodothyronine levels for risk stratification of patients with chronic heart failure. ( Iervasi, G; L'Abbate, A; Landi, P; Pingitore, A; Ripoli, A; Taddei, MC, 2005)
"Levothyroxine treatment is effective in reducing thyroid volume in pediatric patients and is suggested in treatment of goiter caused by AIT, especially in cases of hypothyroid, but also in euthyroid children."	7.73	Levothyroxine treatment reduces thyroid size in children and adolescents with chronic autoimmune thyroiditis. ( Ericsson, UB; Ivarsson, SA; Jonsson, B; Lindberg, B; Nilsson, P; Olsson, C; Svensson, J, 2006)
"Free triiodothyronine (FT3) levels were lower in the T2DM group compared with the nondiabetes group (P = 0."	5.42	Free triiodothyronine levels and short-term prognosis in chronic heart failure patients with type 2 diabetes. ( Chen, P; Lei, X; Li, S; Liu, Z; Luo, Y; Wu, D; Xu, D, 2015)
" These findings indicate that the decrease in optimal daily L-thyroxine dosage reported in previous studies is not a universal finding in all elderly hypothyroid patients; the decrease is present only in patients with associated chronic disorders, and hence may be attributed to the presence of an associated chronic disorder or medications consumed for treatment of these disorders rather than old age."	5.27	Variability of L-thyroxine replacement dose in elderly patients with primary hypothyroidism. ( Kabadi, UM, 1987)
"ātients with end-stage chronic renal failure (CRF) and those receiving dialysis therapy have normal or decreased serum total T4 (TT4), reduced serum total T3 (TT3), and normal total reverse T3 (TrT3) levels."	5.27	Alterations of serum reverse triiodothyronine and thyroxine kinetics in chronic renal failure: role of nutritional status, chronic illness, uremia, and hemodialysis. ( Feinstein, EI; Kaptein, EM; Massry, SG; Nicoloff, JT, 1983)
"When the lymphoma was in remission, her circulating T3 concentration was 2-55 nmol/l but when it relapsed it fell to 0-55 nmol/l."	5.26	Inhibition of conversion of thyroxine to triiodothyronine in patients with severe chronic illness. ( Carter, JN; Corcoran, JM; Eastmen, CJ; Lazarus, L, 1976)
"Fifteen patients who had hypothyroidism caused by CAT and were undergoing levothyroxine (LT4) treatment were selected to participate in the study."	5.14	Low-level laser therapy in chronic autoimmune thyroiditis: a pilot study. ( Cerri, GG; Chammas, MC; Chavantes, MC; Höfling, DB; Juliano, AG; Romão, R; Yoshimura, EM, 2010)
"In this study, 93 chronic inpatients with schizophrenia were comprehensively investigated in order to examine the association of psychiatric and extrapyramidal symptoms with prolactin, thyroid hormones (free triiodothyronine (T₃), free thyroxine (T₄), thyroid stimulating hormone), cortisol and BDNF."	3.78	Triiodothyronine may be possibly associated with better cognitive function and less extrapyramidal symptoms in chronic schizophrenia. ( Hoaki, N; Hoaki, T; Ichioka, S; Matsushita, T; Terao, T, 2012)
"The objective of this paper was to investigate the diagnostic and prognostic value of plasma B type natriuretic peptide (BNP) and serum triiodothyronine (T3) in chronic congestive heart failure (CHF)."	3.78	The role of brain natriuretic peptide and serum triiodothyronine in the diagnosis and prognosis of chronic heart failure. ( Da, CH; Du, JB; Guo, G; Guo, Y; Ju, TF; Xu, YP; Zhao, Y, 2012)
"Although low levels of free triiodothyronine and high levels of brain natriuretic peptide have been shown as independent predictors of death in chronic heart failure patients, few studies have compared their prognostic values."	3.76	Triiodothyronine and brain natriuretic peptide: similar long-term prognostic values for chronic heart failure. ( Acar, E; Ertas, G; Kilic, T; Kozdag, G; Sahin, T; Ural, D, 2010)
" The behavioral and neuroendocrinological effects of icariin, a major constituent of flavonoids isolated from Epimedium brevicornum, were investigated in the CMS model of depression in male Wistar rats."	3.74	Icariin from Epimedium brevicornum attenuates chronic mild stress-induced behavioral and neuroendocrinological alterations in male Wistar rats. ( Jiang, FX; Kong, LD; Kung, HF; Li, YC; Pan, Y; Xia, X, 2007)
" She had been undergoing treatment with methimazole for Graves's hyperthyroidism since the age of 34."	3.73	A case of transient central hyperthyroidism. ( Pishdad, GR; Pishdad, P; Sabzi, A, 2006)
"We sought to explore the use of triiodothyronine (T(3)) concentrations as an adjunct to clinical and functional parameters when estimating prognosis in patients with chronic heart failure."	3.73	Triiodothyronine levels for risk stratification of patients with chronic heart failure. ( Iervasi, G; L'Abbate, A; Landi, P; Pingitore, A; Ripoli, A; Taddei, MC, 2005)
"Levothyroxine treatment is effective in reducing thyroid volume in pediatric patients and is suggested in treatment of goiter caused by AIT, especially in cases of hypothyroid, but also in euthyroid children."	3.73	Levothyroxine treatment reduces thyroid size in children and adolescents with chronic autoimmune thyroiditis. ( Ericsson, UB; Ivarsson, SA; Jonsson, B; Lindberg, B; Nilsson, P; Olsson, C; Svensson, J, 2006)
"Concentrations of triiodothyronine (T3), thyroxine (T4), reflecting the thyroid status, and thyrotropin, a hormone of the anterior pituitary were investigated in 123 patients with exacerbation of chronic pancreatitis."	3.67	[Concentration of thyroid hormones and thyrotropin in the blood of patients with chronic pancreatitis]. ( Abasov, IT; Gidaiatov, AA, 1988)
"Ninety patients aged 41 to 68 years with the chronic patterns of coronary heart disease (CHD) were examined for the content of triiodothyronine (T3), total T4 and free thyroxine (FT4), thyrotropic hormone (TTH), adrenocorticotropic hormone (ACTH), and insulin."	3.67	[Relation between blood levels of thyroid hormones and insulin and lipid metabolism and the clinical course of chronic forms of ischemic heart disease]. ( Dudaev, VA; Gorin, VV; Kliuchnikova, ZhI; Shingireĭ, MV, 1985)
"In order to clarify an alteration in thyroid functions in patients with chronic liver diseases, serum total and free thyroxine (T4, FT4), total and free triiodothyronine (T3, FT3), total reverse T3 (rT3), thyrotropin (TSH), thyroxine-binding globulin (TBG) concentrations, and T3 uptake (T3U) were measured by radioimmunoassays in 53 patients with chronic hepatitis (CH), 24 patients with compensated liver cirrhosis (LC), 17 patients with hepatocellular carcinoma associated with LC (HCC), and 40 normal subjects."	3.67	Thyroid functions in patients with various chronic liver diseases. ( Higashi, K; Sato, T; Shimada, T; Umeda, T, 1988)
" Vitamin A therapy in patients with documented vitamin A deficiency produced an increase in T3, thyroxine (T4), FT3I, FT4I, and free T3 by dialysis, with a concomitant increase in retinol binding protein and no alteration in prealbumin concentrations."	3.66	The interrelationship of thyroid hormones with vitamin A and zinc nutritional status in patients with chronic hepatic and gastrointestinal disorders. ( Carney, EA; Hershman, JM; Morley, JE; Reed, A; Russell, RM, 1981)
" The mean serum concentration of 3,3',5'-triiodothyronine (reverse T3, rT3) was significantly increased in patients with decompensated liver cirrhosis (p less than 0."	3.66	Serum levels of thyroid hormones in liver diseases. ( Ido, K; Kimura, K; Saito, T; Yamanaka, T, 1980)
"Depressed triiodothyronine and elevated reverse triiodothyronine levels are commonly seen in patients with acute and chronic illness and in patients receiving markedly hypocaloric diets."	3.66	Altered thyroid hormone levels in bacterial sepsis: the role of nutritional adequacy. ( Molitch, ME; O'Donnell, TF; Richmand, DA, 1980)
"To further evaluate thyroid function in patients with liver disease, we have measured total and free T3 and T4, thyroxine binding globulin, basal and thyrotropin releasing hormone-stimulated thyrotropin and thyroglobulin antibodies in 33 patients with liver cirrhosis, in 22 with chronic hepatitis and in 30 healthy controls."	3.66	Thyroid function tests in chronic liver disease: evidence for multiple abnormalities despite clinical euthyroidism. ( Borzio, F; Borzio, M; Caldara, R; Ferrari, C; Piepoli, V; Rampini, P, 1983)
"Further, the relapse and recurrence rates within 3 months after respective treatments were also measured."	2.78	Efficacy of repetitive transcranial magnetic stimulation in the treatment of patients with chronic primary insomnia. ( Gao, D; Jiang, CG; Yi, ML; Yue, FG; Zhang, T, 2013)
"Two-thirds of patients with treated hyperthyroidism died."	2.71	Mortality rate of chronically ill geriatric patients with subnormal serum thyrotropin concentration: a 2-yr follow-up study. ( Bernard, W; Feldkamp, J; Horster, FA; Kovács, G; Radácsi, A; Szabolcs, I, 2003)
"During cocaine addiction the hypothalamus-pituitary axis is widely affected and a blunted response of thyroid stimulating hormone (TSH) to thyroid releasing hormone (TRH) consistent with a hyperthyroid state has been observed."	2.69	Thyrotropin-releasing hormone-induced GH release after cocaine withdrawal in cocaine addicts. ( Pezzarossa, A; Vescovi, PP, 1999)
"60 patients with CVMC complicated with arrhythmia were continuously selected (course of disease > 3 months) and they are were diagnosed with arrhythmia by the routine 18-lead electrocardiogram and 24-hour Holter; the average follow-up time is about 2 years, during which the left ventricular end-diastolic diameter (LVEDd), left ventricular ejection fraction (LVEF), the occurrence rate of malignant arrhythmia events, immune state of T cell and thyroid hormone level (FT3, FT4, TSH, TGAb and TPOAb) were compared."	1.46	Relevant researches on chronic viral myocarditis (CVMC) in children, complicated with arrhythmia and thyroid hormone level. ( An, XJ; Fu, MY; Li, CL; Wang, QW; Xu, F; Xue, Y, 2017)
"Free triiodothyronine (FT3) levels were lower in the T2DM group compared with the nondiabetes group (P = 0."	1.42	Free triiodothyronine levels and short-term prognosis in chronic heart failure patients with type 2 diabetes. ( Chen, P; Lei, X; Li, S; Liu, Z; Luo, Y; Wu, D; Xu, D, 2015)
"How the duration of hypothyroidism affects left ventricular diastolic function is not well-characterized."	1.37	Acute and chronic hypothyroidism are associated with similar left ventricular diastolic dysfunction relative to the euthyroid state: results of doppler echocardiographic comparisons. ( Benchuga, G; Gauna, A; Marlowe, RJ; Messuti, H; Papadopulos, G; Silva Croome, MC; Viale, F, 2011)
"Imipramine (IMI) treatment normalized tT4 values."	1.31	Effects of chronic mild stress (CMS) on thyroid hormone function in two rat strains. ( Antoniou, K; Bekris, S; Christofidis, I; Kioukia, N; Papadopoulou-Daifoti, Z, 2000)
"Lithium carbonate was administered for 8 weeks at a dosage giving a mean serum level of 0."	1.29	Possible inhibitory effect of lithium on peripheral conversion of thyroxine to triiodothyronine: a prospective study. ( Nozaki, S; Oga, T; Ohta, A; Okada, M; Otsubo, Y; Terao, T; Yamamoto, S; Zamami, M, 1995)
"Chronic metabolic acidosis has been previously shown to stimulate protein degradation."	1.29	Chronic metabolic acidosis decreases albumin synthesis and induces negative nitrogen balance in humans. ( Anderson, SE; Ballmer, PE; Garlick, PJ; Hulter, HN; Krapf, R; McNurlan, MA, 1995)
"No correlation was found in gastric cancer patients between T3 concentration, degree of blood--T3 level decrease and tissue T3 deficiency, on the one hand, and stage and histologic pattern of tumor, radical surgery and postoperative treatment, on the other."	1.28	[Deficiency of the triiodothyronine pool in patients with stomach cancer]. ( Klimenkov, AA; Sarkisian, RG; Vereshchagina, GV, 1989)
" These findings indicate that the decrease in optimal daily L-thyroxine dosage reported in previous studies is not a universal finding in all elderly hypothyroid patients; the decrease is present only in patients with associated chronic disorders, and hence may be attributed to the presence of an associated chronic disorder or medications consumed for treatment of these disorders rather than old age."	1.27	Variability of L-thyroxine replacement dose in elderly patients with primary hypothyroidism. ( Kabadi, UM, 1987)
"ātients with end-stage chronic renal failure (CRF) and those receiving dialysis therapy have normal or decreased serum total T4 (TT4), reduced serum total T3 (TT3), and normal total reverse T3 (TrT3) levels."	1.27	Alterations of serum reverse triiodothyronine and thyroxine kinetics in chronic renal failure: role of nutritional status, chronic illness, uremia, and hemodialysis. ( Feinstein, EI; Kaptein, EM; Massry, SG; Nicoloff, JT, 1983)
" It is suggested that alcohol may have a toxic effect on the thyroid gland independent of the degree of liver damage."	1.27	Independent effects of liver disease and chronic alcoholism on thyroid function and size: the possibility of a toxic effect of alcohol on the thyroid gland. ( Aldershvile, J; Hegedüs, L; Kastrup, J; Krogsgaard, K; Rasmussen, N; Ravn, V, 1988)
"A 51-year-old woman with chronic lymphocytic thyroiditis showed transient thyrotoxicosis at seven weeks after cessation of steroid therapy for treatment of rheumatoid arthritis."	1.26	Transient thyrotoxicosis occurred after cessation of steroid therapy in a patient with autoimmune thyroiditis and rheumatoid arthritis. ( Kataoka, K; Kato, M; Maruyama, H; Matsuki, S; Mizuno, O, 1982)
"When the lymphoma was in remission, her circulating T3 concentration was 2-55 nmol/l but when it relapsed it fell to 0-55 nmol/l."	1.26	Inhibition of conversion of thyroxine to triiodothyronine in patients with severe chronic illness. ( Carter, JN; Corcoran, JM; Eastmen, CJ; Lazarus, L, 1976)
"Failure to recognize and treat hypothyroidism in these pubertal patients may compromise the adult height, since skeletal maturation will proceed under the influence of sex hormones despite the presence of hypothyroidism."	1.26	Clinical recognition of juvenile hypothyroidism in the early stage. ( Abbassi, V; Cancellieri, RP; Rigterink, E, 1980)

Timeframe	Studies, this research(%)	All Research%
pre-1990	68 (52.71)	18.7374
1990's	20 (15.50)	18.2507
2000's	24 (18.60)	29.6817
2010's	16 (12.40)	24.3611
2020's	1 (0.78)	2.80

Trial	Phase	Enrollment	Study Type	Start Date	Status
A Phase 1b, Open-label Study to Evaluate the Safety and Tolerability of the Putative Remyelinating Agent, Liothyronine, in Individuals With MS[NCT02506751]	Phase 1	20 participants (Actual)	Interventional	2015-07-31	Completed
Long-term Follow-up After Treatment of Chronic Autoimmune Thyroiditis With Low Level Laser[NCT02240563]		43 participants (Actual)	Interventional	2014-09-30	Completed
Evaluation of the Effects of N-acetylcysteine on Thyroid Hormone Levels in the Low T3 Syndrome[NCT01501110]	Phase 4	83 participants (Actual)	Interventional	2011-11-30	Completed
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Intervention	ng/dL (Mean)
N-acetylcysteine	93.5
no Intervention	96.5

Article	Year
[Non thyroidal illnesses (NTIS)]. Annales d'endocrinologie, 2010, Volume: 71 Suppl 1 Topics: Acute Disease; Chronic Disease; Cytokines; Euthyroid Sick Syndromes; Humans; Hydrocortisone; Iodide	2010
Beyond low plasma T3: local thyroid hormone metabolism during inflammation and infection. Endocrine reviews, 2011, Volume: 32, Issue:5 Topics: Acute Disease; Adipose Tissue; Bacterial Infections; Chronic Disease; Euthyroid Sick Syndromes; Gene	2011
Triiodothyronine (T3) and cardiovascular therapeutics: a review. Journal of cardiac surgery, 1992, Volume: 7, Issue:4 Topics: Cardiopulmonary Bypass; Chronic Disease; Heart Failure; Hemodynamics; Humans; Tissue Donors; Triiodo	1992

Article	Year
Efficacy of repetitive transcranial magnetic stimulation in the treatment of patients with chronic primary insomnia. Cell biochemistry and biophysics, 2013, Volume: 67, Issue:1 Topics: Adrenocorticotropic Hormone; Adult; Anti-Anxiety Agents; Chronic Disease; Estazolam; Female; Humans;	2013
Effects of the thyromimetic agent diiodothyropropionic acid on body weight, body mass index, and serum lipoproteins: a pilot prospective, randomized, controlled study. The Journal of clinical endocrinology and metabolism, 2010, Volume: 95, Issue:3 Topics: Aged; Body Mass Index; Body Weight; Chronic Disease; Diiodothyronines; Dose-Response Relationship, D	2010
Low-level laser therapy in chronic autoimmune thyroiditis: a pilot study. Lasers in surgery and medicine, 2010, Volume: 42, Issue:6 Topics: Adult; Autoantibodies; Chronic Disease; Female; Humans; Hypothyroidism; Iodide Peroxidase; Low-Level	2010
Supraphysiological doses of L-thyroxine in the maintenance treatment of prophylaxis-resistant affective disorders. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 2002, Volume: 27, Issue:4 Topics: Adult; Aged; Chronic Disease; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug R	2002
Mortality rate of chronically ill geriatric patients with subnormal serum thyrotropin concentration: a 2-yr follow-up study. Endocrine, 2003, Volume: 21, Issue:2 Topics: Aged; Aged, 80 and over; Aging; Autoantibodies; Chronic Disease; Female; Geriatrics; Humans; Hyperth	2003
Acute effects of triiodothyronine (T3) replacement therapy in patients with chronic heart failure and low-T3 syndrome: a randomized, placebo-controlled study. The Journal of clinical endocrinology and metabolism, 2008, Volume: 93, Issue:4 Topics: Aged; Cardiomyopathy, Dilated; Chronic Disease; Euthyroid Sick Syndromes; Female; Heart; Heart Failu	2008
[Thyroid hormones in patients with acute exacerbations of pneumoconiosis]. Nihon Kyobu Shikkan Gakkai zasshi, 1995, Volume: 33, Issue:8 Topics: Aged; Biomarkers; Chronic Disease; Female; Humans; Male; Middle Aged; Pneumoconiosis; Prognosis; Tri	1995
Thyrotropin-releasing hormone-induced GH release after cocaine withdrawal in cocaine addicts. Neuropeptides, 1999, Volume: 33, Issue:6 Topics: Adult; Chronic Disease; Cocaine-Related Disorders; Human Growth Hormone; Humans; Male; Substance Wit	1999
Monoamine oxidase in chronic schizophrenia: Studies of hormonal and other factors affecting enzyme activity. The British journal of psychiatry : the journal of mental science, 1977, Volume: 130 Topics: Benzylamines; Blood Platelets; Chronic Disease; Clinical Trials as Topic; Female; Humans; Iron; Male	1977
Effect of triiodo - thyronine on bronchial asthma. The Journal of the Egyptian Medical Association, 1974, Volume: 57, Issue:9-10 Topics: Adult; Asthma; Chronic Disease; Clinical Trials as Topic; Humans; Norepinephrine; Triiodothyronine	1974

triiodothyronine and Chronic Illness

Research Excerpts

Research

Studies (129)

Authors

Clinical Trials (3)

Trial Overview

Trial Outcomes

Serum T3 Levels at 48 Hours

Reviews

Trials

Other Studies

Authors	Studies
Zheng, X	1
Jin, Y	1
Xu, T	1
Xu, H	1
Zhu, S	1
Qu, P	1
Yu, JX	1
Xia, L	1
Chen, GH	1
Ohba, K	1
Sinha, RA	1
Singh, BK	1
Iannucci, LF	1
Zhou, J	1
Kovalik, JP	1
Liao, XH	1
Refetoff, S	1
Sng, JCG	1
Leow, MK	1
Yen, PM	1
Fu, MY	1
Wang, QW	1
Xue, Y	1
Xu, F	1
Li, CL	1
An, XJ	1
Jiang, CG	1
Zhang, T	1
Yue, FG	1
Yi, ML	1
Gao, D	1
Chen, P	1
Li, S	1
Lei, X	1
Liu, Z	1
Wu, D	1
Luo, Y	1
Xu, D	1
Şıklar, Z	1
Karataş, D	1
Doğu, F	1
Hacıhamdioğlu, B	1
İkincioğulları, A	1
Berberoğlu, M	1
Forestier, E	1
Vinzio, S	1
Sapin, R	3
Schlienger, JL	2
Goichot, B	2
Iacoviello, M	1
Guida, P	1
Guastamacchia, E	1
Triggiani, V	1
Forleo, C	1
Catanzaro, R	1
Cicala, M	1
Basile, M	1
Sorrentino, S	1
Favale, S	1
Karlsson, H	1
Song, SH	1
Kwak, IS	1
Lee, DW	1
Kang, YH	1
Seong, EY	1
Park, JS	1
Harsan, LA	1
Steibel, J	1
Zaremba, A	1
Agin, A	1
Poulet, P	1
Guignard, B	1
Parizel, N	1
Grucker, D	1
Boehm, N	1
Miller, RH	1
Ghandour, MS	1
Ladenson, PW	1
McCarren, M	1
Morkin, E	1
Edson, RG	1
Shih, MC	1
Warren, SR	1
Barnhill, JG	1
Churby, L	1
Thai, H	1
O'Brien, T	1
Anand, I	1
Warner, A	1
Hattler, B	1
Dunlap, M	1
Erikson, J	1
Goldman, S	1
Höfling, DB	1
Chavantes, MC	1
Juliano, AG	1
Cerri, GG	1
Romão, R	1
Yoshimura, EM	1
Chammas, MC	1
Corsonello, A	1
Montesanto, A	1
Berardelli, M	1
De Rango, F	1
Dato, S	1
Mari, V	1
Mazzei, B	1
Lattanzio, F	1
Passarino, G	1
Kozdag, G	1
Ertas, G	1
Kilic, T	1
Acar, E	1
Sahin, T	1
Ural, D	1
Luca, F	1
Brue, T	1
Gauna, A	1
Messuti, H	1
Papadopulos, G	1
Benchuga, G	1
Viale, F	1
Marlowe, RJ	1
Silva Croome, MC	1
Boelen, A	1
Kwakkel, J	1
Fliers, E	1
Vitale, J	1
Fesce, E	1
Schmidt, G	1
Ichioka, S	1
Terao, T	2
Hoaki, N	1
Matsushita, T	1
Hoaki, T	1
Du, JB	1
Da, CH	1
Zhao, Y	1
Guo, Y	1
Guo, G	1
Ju, TF	1
Xu, YP	1
Bauer, M	1
Berghöfer, A	1
Bschor, T	1
Baumgartner, A	1
Kiesslinger, U	1
Hellweg, R	1
Adli, M	1
Baethge, C	1
Müller-Oerlinghausen, B	1
Varas, SM	1
Muñoz, EM	1
Hapon, MB	1
Aguilera Merlo, CI	1
Giménez, MS	1
Jahn, GA	1
Radácsi, A	1
Kovács, G	1
Bernard, W	1
Feldkamp, J	1
Horster, FA	1
Szabolcs, I	1
Liu, YY	1
Yang, N	1
Kong, LN	1
Zuo, PP	1
Scoscia, E	1
Baglioni, S	1
Eslami, A	1
Iervasi, G	3
Monti, S	1
Todisco, T	1
Pingitore, A	2
Landi, P	1
Taddei, MC	1
Ripoli, A	1
L'Abbate, A	2
Palma-Carlos, AG	1
Palma-Carlos, ML	1
Helmreich, DL	1
Parfitt, DB	1
Lu, XY	1
Akil, H	1
Watson, SJ	1
Svensson, J	1
Ericsson, UB	1
Nilsson, P	1
Olsson, C	1
Jonsson, B	1
Lindberg, B	1
Ivarsson, SA	1
Briukhin, GV	1
Nikolina, OV	1
Barysheva, SV	1
Pishdad, GR	1
Pishdad, P	1
Sabzi, A	1
Kumar, A	1
Varshney, JP	1
Varshney, VP	1
Pan, Y	1
Kong, LD	1
Li, YC	1
Xia, X	1
Kung, HF	1
Jiang, FX	1
Fardella, CE	1
Artigas, RA	1
Gloger, S	1
Jiménez, M	1
Carvajal, CA	1
Krall, PM	1
Quiroz, D	1
Campino, C	1
Mosso, LM	1
Lin, H	1
De Vos, D	1
Decuypere, E	1
Buyse, J	1
Galli, E	1
Barison, A	1
Iervasi, A	1
Scarlattini, M	1
Nucci, D	1
Mariotti, R	1
Nihei, N	1
Melmed, S	1
Geola, FL	1
Reed, AW	1
Pekary, AE	1
Park, J	1
Hershman, JM	2
Borzio, M	1
Caldara, R	1
Borzio, F	1
Piepoli, V	1
Rampini, P	1
Ferrari, C	1
Ando, K	1
Saito, K	1
Takai, T	1
Yamamoto, K	1
Kuzuya, T	1
Yoshida, S	1
Takeda, A	1
Minato, N	1
Kano, S	1
Kaptein, EM	1
Feinstein, EI	1
Nicoloff, JT	1
Massry, SG	1
Jonderko, G	2
Kita, K	2
Pietrzak, J	2
Primus-Słowińska, B	2
Rurańska, B	2
Zyłka-Włoszczyk, M	2
Straszecka, J	1
Krzewiński, W	1
Mizukami, Y	1
Matsubara, F	2
Tyzbir, RS	1
Kunin, AS	1
Medeiros-Neto, GA	1
de Kallas, WG	1
Cavaliere, H	1
Knobel, M	1
Mattar, E	1
Cambieri, A	1
Altomonte, L	1
Greco, AV	1
Scrimieri, D	1
Pepe, M	1
Abbassi, V	1
Rigterink, E	1
Cancellieri, RP	1
Maruyama, H	1
Kato, M	1
Mizuno, O	1
Kataoka, K	1
Matsuki, S	1
Caplan, RH	1
Wickus, G	1
Glasser, JE	1
Davis, K	1
Wahner, HW	1
Iwaoka, T	1
Umeda, T	2
Nakayama, M	1
Shimada, T	2
Fujii, Y	1
Miura, F	1
Sato, T	2
Oppenheimer, JH	1
Natarov, VV	1
Gladkova, AI	1
Pesotskaia, PM	1
Morley, JE	1
Russell, RM	1
Reed, A	1
Carney, EA	1
Kuch, J	1
Piwowarczyk, K	1
Luczak, D	1
Biro, E	1
Giudici Cipriani, A	1
Marenco, G	1
Artom, A	1
Menardo, G	1
Colombo, P	1
Rembado, R	1
Barbetti, V	1
Yamanaka, T	1
Ido, K	1
Kimura, K	1
Saito, T	1
Richmand, DA	1
Molitch, ME	1
O'Donnell, TF	1
Hieda, M	1
Kawakami, M	1
Usami, I	1
Kuroki, H	1
Goto, M	1
Oga, T	1
Nozaki, S	1
Ohta, A	1
Otsubo, Y	1
Yamamoto, S	1
Zamami, M	1
Okada, M	1
Kumar, PN	1
Aruldhas, MM	1
Juneja, SC	1
Ballmer, PE	1
McNurlan, MA	1
Hulter, HN	1
Anderson, SE	1
Garlick, PJ	1
Krapf, R	1
Bianchi, G	1
Marchesini, G	1
Zoli, M	1
Falasconi, MC	1
Iervese, T	1
Vecchi, F	1
Magalotti, D	1
Ferri, S	1
Han, MX	1
Wang, YP	1
Gøtzsche, LB	1
Rosenqvist, N	1
Grønbaek, H	1
Flyvbjerg, A	1
Gøtzsche, O	1
Pissarek, M	1
Bigard, X	1
Mateo, P	1
Guezennec, CY	1
Hoerter, JA	1
Vlasova, VV	1
Lantsov, AA	1
Khmel'nitskaia, NM	1
Marwaha, RK	1
Sankar, R	1
Magdum, M	1
Nijahvan, VS	1
Khanna, CM	1
Jaggi, CB	1
Ambardar, V	1
Maharda, NS	1
Walia, RP	1
Jain, SK	1
Vescovi, PP	1
Pezzarossa, A	1
Kioukia, N	1
Bekris, S	1
Antoniou, K	1
Papadopoulou-Daifoti, Z	1
Christofidis, I	1
Cremaschi, GA	1
Gorelik, G	1
Klecha, AJ	1
Lysionek, AE	1
Genaro, AM	1
Pantos, CI	1
Malliopoulou, VA	1
Mourouzis, IS	1
Karamanoli, EP	1
Tzeis, SM	1
Carageorgiou, HC	1
Varonos, DD	1
Cokkinos, DV	1
Ginsberg, J	1
Walfish, PG	1
Tamai, H	1
Suematsu, H	1
Esaki, M	1
Kurakawa, N	1
Aoki, H	1
Schussler, GC	1
Schaffner, F	1
Korn, F	1
Sheridan, P	1
Losowsky, MS	1
Kawato, M	2
Carter, JN	3
Eastman, CJ	2
Corcoran, JM	3
Lazarus, L	3
Murphy, DL	1
Belmaker, R	1
Carpenter, WT	1
Wyatt, RJ	1
Finucane, JF	1
Griffiths, RS	1
Black, EG	1
Hall, CL	1
Sasaki, N	1
Ogata, M	1
Nakamura, Y	1
Niimi, H	1
Carella, C	1
Del Vecchio-Blanco, C	1
Pisano, G	1
Biscaglia, G	1
Caporaso, N	1
Takeda, R	1
Nakabayashi, H	1
Ueda, M	1
Riesco, G	1
Taurog, A	1
Larsen, R	1
Krulich, L	1
Eastmen, CJ	1
Comtois, R	1
Hébert, J	1
Soucy, JP	1
Strobl, W	1
Chan, L	1
Patsch, W	1
Salter, DR	1
Dyke, CM	1
Wechsler, AS	1
Federman, DD	1
Gasser, F	1
Fagerberg, B	1
Nyström, E	1
Sjöström, L	1
Lundberg, PA	1
Darpö, B	1
Lindstedt, G	1
Kalisnik, M	1
Zorc-Pleskovic, R	1
Pajer, Z	1
Pavlin, K	1
Liu, K	1
Felzen, B	1
Sweed, Y	1
Binah, O	1
Vereshchagina, GV	1
Klimenkov, AA	1
Sarkisian, RG	1
Lonati-Galligani, M	1
Shi, G	1
Wang, G	1
Dudaev, VA	1
Gorin, VV	1
Shingireĭ, MV	1
Kliuchnikova, ZhI	1
Kabadi, UM	1
Bauer, AG	1
Wilson, JH	1
Lamberts, SW	1
Docter, R	1
Hennemann, G	1
Visser, TJ	1
Higashi, K	1
Gidaiatov, AA	1
Abasov, IT	1
Hegedüs, L	1
Rasmussen, N	1
Ravn, V	1
Kastrup, J	1
Krogsgaard, K	1
Aldershvile, J	1
Itoh, S	1
Yamaba, Y	1
Oda, T	1
Kawagoe, K	1
Campanini, M	1
Saglietti, G	1
Zaccala, G	1
Occhipinti, P	1
Cardano, S	1
Monteverde, A	1
Barsano, CP	1
Burke, SF	1
Quintana, M	1
Quintanilla, A	1
Iqbal, Z	1
Munoz, E	1
McLarty, DG	1
Alexander, WD	1
Harden, RM	1
Robertson, JW	1
Matsumoto, N	1
Horino, M	1
Kobayashi, K	1
Nakajima, K	1
Matsumura, S	1
Slavnov, VN	1
Hales, I	1
Reeve, T	1
Myhill, J	1
Dowda, K	1
Shichijo, K	1
Greenberg, AH	1
Czernichow, P	1
Hung, W	1
Shelley, W	1
Winship, T	1
Blizzard, RM	1
Joasoo, A	1
Murray, IP	1
Parkin, J	1
Robertson, MR	1
Jeremy, D	1
Piatnek-Leunissen, DA	2
Leunissen, RL	2
Danilova, IN	1
Minenkov, AA	1
Ismail, AA	1
Shalaby, E	1
Gadalla, I	1
Földes, J	1
Gyertyánfy, G	1
Tako, J	1
Bános, C	1
Gesztesi, E	1
Sakurada, T	2
Saito, S	1
Yamamoto, M	2
Yamaguchi, T	2
Yoshida, K	2
Otaki, M	1
Shimoda, S	1
Kuniyoshi, N	1
Sugita, Y	1
Tabei, A	1
Shimojo, H	1
Grebe, SF	1
Schultis, K	1
Klug, W	1